Genes for five different 5-HT3 receptor subunits have been identified. Most of the subunits have multiple isoforms, but two isoforms of the B subunits, brain-type 1 (Br1) and brain-type 2 (Br2) are of particular interest as they appear to be abundantly expressed in human brain, where 5-HT3B subunit RNA consists of approximately 75% 5-HT3Br2, 24% 5-HT3Br1, and <1% 5-HT3B. Here we use two-electrode voltage-clamp, radioligand binding, fluorescence, whole cell, and single channel patch-clamp studies to characterize the roles of 5-HT3Br1 and 5-HT3Br2 subunits on function and pharmacology in heterologously expressed 5-HT3 receptors. The data show that the 5-HT3Br1 transcriptional variant, when coexpressed with 5-HT3A subunits, alters the EC50, nH, and single channel conductance of the 5-HT3 receptor, but has no effect on the potency of competitive antagonists; thus, 5-HT3ABr1 receptors have the same characteristics as 5-HT3AB receptors. There were some differences in the shapes of 5-HT3AB and 5-HT3ABr1 receptor responses, which were likely due to a greater proportion of homomeric 5-HT3A versus heteromeric 5-HT3ABr1 receptors in the latter, as expression of the 5-HT3Br1 compared to the 5-HT3B subunit is less efficient. Conversely, the 5-HT3Br2 subunit does not appear to form functional channels with the 5-HT3A subunit in either oocytes or HEK293 cells, and the role of this subunit is yet to be determined.
Genes for five different 5-HT3 receptor subunits have been identified. Most of the subunits have multiple isoforms, but two isoforms of the B subunits, brain-type 1 (Br1) and brain-type 2 (Br2) are of particular interest as they appear to be abundantly expressed in human brain, where 5-HT3B subunit RNA consists of approximately 75% 5-HT3Br2, 24% 5-HT3Br1, and <1% 5-HT3B. Here we use two-electrode voltage-clamp, radioligand binding, fluorescence, whole cell, and single channel patch-clamp studies to characterize the roles of 5-HT3Br1 and 5-HT3Br2 subunits on function and pharmacology in heterologously expressed 5-HT3 receptors. The data show that the 5-HT3Br1 transcriptional variant, when coexpressed with 5-HT3A subunits, alters the EC50, nH, and single channel conductance of the 5-HT3 receptor, but has no effect on the potency of competitive antagonists; thus, 5-HT3ABr1 receptors have the same characteristics as 5-HT3AB receptors. There were some differences in the shapes of 5-HT3AB and 5-HT3ABr1 receptor responses, which were likely due to a greater proportion of homomeric 5-HT3A versus heteromeric 5-HT3ABr1 receptors in the latter, as expression of the 5-HT3Br1 compared to the 5-HT3B subunit is less efficient. Conversely, the 5-HT3Br2 subunit does not appear to form functional channels with the 5-HT3A subunit in either oocytes or HEK293 cells, and the role of this subunit is yet to be determined.
Entities:
Keywords:
Serotonin; cys-loop; heteromeric; single channel
5-HT3 receptors are members of the
Cys-loop family of
ligand-gated ion channels that are responsible for fast excitatory
and inhibitory synaptic transmission in the central and peripheral
nervous systems. Other members of this family include the nACh, GABA,
and glycine receptors, all of which share a common structural arrangement
and are targets for a range of clinically important drugs.[1−4]Cys-loop receptors consist of five subunits that surround
a central
ion-conducting pore. Each subunit can be divided into three functionally
distinct regions that are termed the intracellular, transmembrane,
and extracellular domains. The intracellular domain, whose structure
is not yet known, is responsible for post-translational modulation
by intracellular molecules and plays a role in channel conductance.[3,5] The transmembrane domain consists of four membrane-spanning α-helices
(M1–M4); M2 lines the pore, enabling ions to pass through the
channel. In 5-HT3 receptors, the pore is cation selective,
and its opening results in a rapidly activating and then desensitizing
inward current that depolarizes the cell. The extracellular domain
contains the ligand binding sites for agonist and competitive antagonists
and these are formed by the convergence of six amino acid loops at
the interface of two adjacent subunits. Three loops (A–C) arise
from the principal subunit and three (D–F) from the complementary
subunit. The amino acids responsible for interacting with ligands
vary according to the ligand and receptor being studied, but all binding
pockets possess three to five aromatic residues that contribute to
an “aromatic box” which is important for binding ligands.To date, genes for five 5-HT3 receptor subunits have
been identified (5-HT3A–5-HT3E) in humans.[6] Only 5-HT3A subunits can form functional homomeric receptors,
and the structure of the mouse 5-HT3A receptor has recently
been solved to high resolution.[7] The other
subunits can combine with 5-HT3A to form heteromeric complexes, but,
apart from receptors expressing 5-HT3A and 5HT3B subunits (5-HT3AB receptors), these have not been extensively investigated.[8−10] Most of the subunits have multiple isoforms, but two isoforms of
the 5-HT3B subunits, brain-type 1 and brain-type 2 (called here 5-HT3Br1
and 5-HT3Br2 rather than 5-HT3BBr1/2), are of particular interest
as their RNAs are abundantly expressed in human brain.[11] These authors reported that in brain less than
1% of the 5-HT3B subunit RNA coded for the conventional 5-HT3B subunit,
while the remaining B-subunit RNA was accounted for by approximately
75% 5-HT3Br2 and 24% 5-HT3Br1. There is therefore the potential that
5-HT3AB receptors in the brain have distinct properties
to those in other regions. As 5-HT3 receptor-selective
agents have a range of therapeutic applications it is important to
better understand the consequences of incorporating these subunits
on the pharmacology and physiology of these receptors.The aim
of this study was to assess the functional role of 5-HT3AB receptors containing 5-HT3Br1 or 5-HT3Br2 subunits, which
differ only in their N-terminal sequences (Figure 1) compared to the originally described 5-HT3B subunit. We
do this using a combination of two-electrode voltage-clamp, radioligand
binding, fluorescence, and whole cell and single channel patch-clamp
studies.
Figure 1
Alignment of the N-terminal region of 5-HT3B, 5-HT3Br1, and 5-HT3Br2
subunits. 5HT3Br1 subunits differ from 5-HT3B subunits only in the
extreme N-terminus, while 5HT3Br2 has ∼100 fewer amino acids
and is missing the β1 and β2/loop D regions. Differences
in the subunits are due to alternative splicing so the remaining sequences
are identical.
Alignment of the N-terminal region of 5-HT3B, 5-HT3Br1, and 5-HT3Br2
subunits. 5HT3Br1 subunits differ from 5-HT3B subunits only in the
extreme N-terminus, while 5HT3Br2 has ∼100 fewer amino acids
and is missing the β1 and β2/loop D regions. Differences
in the subunits are due to alternative splicing so the remaining sequences
are identical.
Results and Discussion
Characterization
of 5-HT3A and 5-HT3AB
Receptors
Application of 5-HT to Xenopus oocytes expressing homomeric or heteromeric receptors produced rapidly
activating inward currents that desensitized over the time-course
of the application (Figure 2). The shape of
the responses elicited by 5-HT3A and 5-HT3AB
receptors differed due to faster desensitization of the latter. Concentration–response
curves for 5-HT3A and 5-HT3AB receptors also
showed differences in 5-HT EC50, which was increased in
5-HT3AB compared to 5-HT3A receptors, and Hill
slope, which was reduced (Table 1, Figure 2) as previously published.[8−10] Similar differences
in EC50 and nH were observed
for receptors expressed in HEK293 cells, with functional responses
measured using a fluorescent membrane potential sensitive dye; EC50 was increased and nH decreased
in 5-HT3AB compared to 5-HT3A receptors. Here
again there were differences in the shape of the responses: 5-HT3A receptor responses peaked and returned toward baseline over
the course of the experiment, while 5-HT3AB responses peaked
more slowly and only decreased toward baseline at lower 5-HT concentrations
(Figure 3).
Figure 2
Traces of macroscopic currents from 5-HT3 receptors
expressed in oocytes measured using voltage clamp electrophysiology.
Typical examples of current traces over a range of 5-HT concentrations
for 5-HT3A, 5-HT3AB, 5-HT3ABr1, and
5-HT3ABr2 receptors from the same batch of oocytes are
shown. There are distinct differences in the shapes of all the currents.
Table 1
Parameters Derived from 5-HT-Induced
Macroscopic Responses of 5-HT3 Receptors Expressed in Oocytes
receptor
pEC50 (M) mean ± SEM
nH
n
5-HT3A
5.76 ± 0.02
2.6
6
5-HT3AB
4.55 ± 0.04a
1.0
7
5-HT3ABr1
5.09 ± 0.06a
1.0
8
5-HT3ABr2
5.48 ± 0.04b
1.9
6
Significantly different from 5-HT3A receptors, p < 0.05.
Significantly different from 5-HT3AB receptors, p < 0.05
Figure 3
Responses from 5-HT3 receptors expressed
in HEK293 cells
measured using a fluorescent membrane potential sensitive dye. Typical
examples of 5-HT-induced responses over a range of 5-HT concentrations
for 5-HT3A, 5-HT3AB, 5-HT3ABr1, and
5-HT3ABr2 receptors are shown. The response profiles of
5-HT3A and 5-HT3AB receptors are different,
with 5-HT3ABr1 receptor responses similar to 5-HT3AB receptor responses, and 5HT3Br2 receptor responses
similar to 5-HT3A receptor responses. F = arbitrary fluorescent units.
Traces of macroscopic currents from 5-HT3 receptors
expressed in oocytes measured using voltage clamp electrophysiology.
Typical examples of current traces over a range of 5-HT concentrations
for 5-HT3A, 5-HT3AB, 5-HT3ABr1, and
5-HT3ABr2 receptors from the same batch of oocytes are
shown. There are distinct differences in the shapes of all the currents.Responses from 5-HT3 receptors expressed
in HEK293 cells
measured using a fluorescent membrane potential sensitive dye. Typical
examples of 5-HT-induced responses over a range of 5-HT concentrations
for 5-HT3A, 5-HT3AB, 5-HT3ABr1, and
5-HT3ABr2 receptors are shown. The response profiles of
5-HT3A and 5-HT3AB receptors are different,
with 5-HT3ABr1 receptor responses similar to 5-HT3AB receptor responses, and 5HT3Br2 receptor responses
similar to 5-HT3A receptor responses. F = arbitrary fluorescent units.Significantly different from 5-HT3A receptors, p < 0.05.Significantly different from 5-HT3AB receptors, p < 0.05
Characterization of 5-HT3ABr1
Receptors in Oocytes
Coexpression of 5-HT3Br1 with 5-HT3A
subunits produced currents
in Xenopus oocytes with concentration–response
parameters that were similar to 5-HT3AB receptors. This
was expected as the amino acid composition of the 5-HT3Br1 subunit
is very similar to that of the 5-HT3B subunit, with the only difference
being a region at the extreme N-terminus of the subunit (Figure 1). This region is likely to be predominantly, if
not solely, part of the signal sequence, and thus is not likely to
be expressed in the mature protein. However, the shape of the responses
in 5-HT3ABr1 receptors differed from those in 5-HT3AB receptors, being somewhat intermediate between those of
5-HT3A and 5-HT3AB receptors (Figure 2), with fast desensitization at high 5-HT concentration
but slower desensitization at low concentrations. These differences
likely arise as these cells can express both homomeric (5-HT3A) and heteromeric receptors (5-HT3AB/Br1), and the proportions
of these may differ depending on which B subunit is being expressed.
It is also possible that differential B subunit expression could cause
different stoichiometries, and different characteristics, as is the
case in certain nACh receptors,[12] although
there is currently no evidence for this.
Characterization of 5-HT3ABr1 Receptors in HEK Cells
Coexpression of 5-HT3A
and 5-HT3Br1 subunits in HEK cells analyzed
using membrane potential fluorescent dye revealed shapes of 5-HT-induced
responses that were not significantly different to those of 5-HT3AB receptors (Figure 3). The 5-HT3ABr1 concentration–response curves were right shifted
and had lower Hill slopes when compared to 5-HT3A receptors,
consistent with voltage clamp measurements in oocytes (Table 2).
Table 2
Parameters Derived
from 5-HT3 Receptors Expressed in HEK293 Cells Using a
Membrane Potential Dye
or Radioligand Bindinga
parameters
from functional data
receptor
pEC50 (M)
nH
Kd (nM) from [3H]granisetron binding
data
5-HT3A
6.56 ± 0.02
3.6 ± 0.8
0.33 ± 0.02
5-HT3AB
5.81 ± 0.06b
1.3 ± 0.2b
0.25 ± 0.08
5-HT3ABr1
5.79 ± 0.08b
1.5 ± 0.3b
0.35 ± 0.09
5-HT3ABr2
6.43 ± 0.06c
2.9 ± 0.4c
0.41 ± 0.11
Data = mean ±
SEM, n = 3–8.
Significantly different from 5-HT3A receptors, p < 0.05.
Significantly
different from 5-HT3AB receptors, p <
0.05
Data = mean ±
SEM, n = 3–8.Significantly different from 5-HT3A receptors, p < 0.05.Significantly
different from 5-HT3AB receptors, p <
0.05The 5-HT3Br1 subunit,
however, was expressed and/or incorporated
into functional receptors over a different time course and concentration
range when compared to the 5-HT3B subunit: higher concentrations and
a longer period after transfection were needed to obtain similar effects.
Figure 4 shows the effects on receptor parameters
determined 2 or 3 days post transfection. Analysis of data obtained
2 days post transfection with 2 or 20 ng 5-HT3B subunit cDNA (both
combined with 20 ng 5-HT3A subunit cDNA) revealed receptor characteristics
that were consistent with 5-HT3AB receptors, but such characteristics
were not apparent in cells transfected with 5-HT3Br1 subunit cDNA
until at least 3 days post transfection and required >20 ng 5-HT3Br1
subunit cDNA. These data show that the signal sequence has a significant
effect on expression and/or subsequent incorporation of the 5-HT3Br1
subunit into functional receptors, and support the expression hypothesis
proposed above (different relative expression levels of homomeric
and heteromeric receptors) to explain the different traces in 5-HT3AB and 5-HT3ABr1 receptors. Given these data, a
study of the levels of expression of the 5-HT3Br1 subunit protein
in brain tissues would be worthwhile, as the data showing high levels
of 5-HT3Br1 subunit RNA in neurones may not provide an accurate picture
of the relative proportions of different types of 5-HT3 receptor subunits being expressed.
Figure 4
Appearance of 5-HT3AB receptor
characteristics differ
following transfection with 5-HT3B or 5-HT3Br1 subunits. Cells were
transfected with 5-HT3A subunit cDNA (20 ng per well) and various
amounts of 5-HT3B or 5-HT3Br1 subunit DNA, and incubated for 2 (A)
or 3 (B) days. Higher EC50 and lower nH values (i.e., 5-HT3AB receptor characteristics)
were observed in cells incubated for 2 days with 2 and 20 ng of 5-HT3B
subunit cDNA, but those transfected with 0.2 ng of cDNA had responses
with characteristics consistent with homomeric 5-HT3A receptors.
Cells transfected with 200 ng of 5-HT3BR1 subunit cDNA had 5-HT3AB receptor characteristics after 3 days of incubation. Responses
with characteristics consistent with homomeric 5-HT3A receptors
were observed for cells transfected with 2 or 20 ng of cDNA, and for
cells incubated for 2 days (data not shown). Data = mean ± SEM, n = 3–6;*significantly different from 5-HT3A receptor responses.
Appearance of 5-HT3AB receptor
characteristics differ
following transfection with 5-HT3B or 5-HT3Br1 subunits. Cells were
transfected with 5-HT3A subunit cDNA (20 ng per well) and various
amounts of 5-HT3B or 5-HT3Br1 subunit DNA, and incubated for 2 (A)
or 3 (B) days. Higher EC50 and lower nH values (i.e., 5-HT3AB receptor characteristics)
were observed in cells incubated for 2 days with 2 and 20 ng of 5-HT3B
subunit cDNA, but those transfected with 0.2 ng of cDNA had responses
with characteristics consistent with homomeric 5-HT3A receptors.
Cells transfected with 200 ng of 5-HT3BR1 subunit cDNA had 5-HT3AB receptor characteristics after 3 days of incubation. Responses
with characteristics consistent with homomeric 5-HT3A receptors
were observed for cells transfected with 2 or 20 ng of cDNA, and for
cells incubated for 2 days (data not shown). Data = mean ± SEM, n = 3–6;*significantly different from 5-HT3A receptor responses.Radioligand binding with the 5-HT3–receptor
selective
antagonist [3H]granisetron revealed no differences in the Kd values of 5-HT3AB and 5-HT3ABr1 receptors, and these were also similar to values from
5-HT3A receptors (Table 2). We also
determined Ki values for a range of competitive
antagonists, and all competed with similar affinities with a rank
order of potency of palonosetron > granisetron > MDL-72222 >
mCPBG
> d-TC (Figure 5). These data are consistent
with previous studies on 5-HT3A and 5-HT3AB
receptors that have demonstrated similar antagonist affinities for
a range of compounds, despite some biophysical differences between
homomeric and heteromeric receptors. This similarity can be readily
explained if the binding site for these ligands is at an interface
between two adjacent 5-HT3A subunits, which is consistent with the
reduced Hill slope of 5-HT concentration–response curve at
heteromeric receptors, and our previous findings that mutations to
residues in either the principal or complementary face of the 5-HT3B-subunit
binding site do not alter ligand binding.[13] Indeed there is good evidence from FRET studies that the orthosteric
binding site is located between two adjacent 5-HT3A subunits in both
5-HT3A and 5-HT3AB receptors.[14]
Figure 5
Potencies of ligands at different 5-HT3 receptors expressed
in HEK293 cells. The Ki values of a range
of competitive 5-HT3 receptor ligands were not significantly
different for all the different subtypes. Data = mean ± SEM, n = 3–6.
Potencies of ligands at different 5-HT3 receptors expressed
in HEK293 cells. The Ki values of a range
of competitive 5-HT3 receptor ligands were not significantly
different for all the different subtypes. Data = mean ± SEM, n = 3–6.To further probe any differences between 5-HT3AB and
5-HT3ABr1 receptors we explored their single channel currents.
Single-channel recordings from cell-attached patches of HEK293 cells
expressing 5-HT3AB and 5-HT3ABr1 receptors (1:3
A:B or Br1 ratio) in the presence of 10 μM 5-HT revealed that
activation occurred in bursts composed of closely spaced openings
separated by brief closed periods. The mean amplitude of single channel
openings at −70 mV was 1.95 ± 0.06 pA and 2.17 ±
0.15 pA for 5-HT3AB and 5-HT3ABr1 receptors
respectively (n = 3), and increased with the decrease
of membrane potential (2.9 ± 0.2 and 3.2 ± 0.3 pA, respectively,
at −100 mV; Figure 6). The relationship
between membrane potential and mean amplitude of the events yielded
an estimated conductance of 30 ± 1.2 pS and 33 ± 1.1 pS
for 5-HT3AB and 5-HT3ABr1 receptors, respectively
(Figure 7). For both receptors, open time histograms
were fitted by two exponential components with no significant differences
in the mean duration of each component (Figure 6). The mean durations of both components at −100 mV were 3.9
± 0.9 ms and 0.14 ± 0.05 ms for 5-HT3AB (n = 6), and 3.6 ± 0.6 ms and 0.11 ± 0.03 ms for
5-HT3ABr1 (n = 4) (p >
0.1). In addition, the mean burst duration did not differ between
5-HT3AB (13.5 ± 4.0 ms, n = 6) and
5-HT3ABr1 receptors (14.2 ± 5.20 ms, n = 4) (p > 0.1). Thus, the data show there are
no
significant differences between single-channel properties of 5-HT3AB and 5-HT3ABr1 receptors.
Figure 6
Single-channel currents
of 5-HT3AB and 5-HT3ABr1 receptors expressed
in HEK293 cells. Single channels activated
by 10 μM 5-HT were recorded from cells transfected with 5-HT3A
together with 5-HT3B or 5-HT3Br1 subunits (1:3 A:B or Br1 ratio; total
DNA, 4 μg/dish). Recordings were made 3 days after transfection.
Channels are shown as upward deflections at different membrane potentials
and two different temporal scales for each receptor. Filter: 10 kHz.
Representative amplitude histograms at different membrane potentials
are shown. At the bottom, representative open- and burst-duration
histograms for each receptor at −100 mV are shown.
Figure 7
Current–voltage (IV) relationships for 5-HT3AB
and 5-HT3ABr1 receptors expressed in HEK293 cells. Data
corresponds to the mean amplitude (I) ± SD for
at least 160 opening events from three different cells, transfected
as in Figure 6, for each condition. The mean
amplitude was obtained from the corresponding amplitude histogram.
The conductance was obtained from the slope of the curve. Data are
not significantly different (p > 0.05).
Single-channel currents
of 5-HT3AB and 5-HT3ABr1 receptors expressed
in HEK293 cells. Single channels activated
by 10 μM 5-HT were recorded from cells transfected with 5-HT3A
together with 5-HT3B or 5-HT3Br1 subunits (1:3 A:B or Br1 ratio; total
DNA, 4 μg/dish). Recordings were made 3 days after transfection.
Channels are shown as upward deflections at different membrane potentials
and two different temporal scales for each receptor. Filter: 10 kHz.
Representative amplitude histograms at different membrane potentials
are shown. At the bottom, representative open- and burst-duration
histograms for each receptor at −100 mV are shown.Current–voltage (IV) relationships for 5-HT3AB
and 5-HT3ABr1 receptors expressed in HEK293 cells. Data
corresponds to the mean amplitude (I) ± SD for
at least 160 opening events from three different cells, transfected
as in Figure 6, for each condition. The mean
amplitude was obtained from the corresponding amplitude histogram.
The conductance was obtained from the slope of the curve. Data are
not significantly different (p > 0.05).
Characterization of 5-HT3ABr2 Receptors in Oocytes
The shape of the responses
in oocytes following coinjection of
mRNA for 5-HT3A and 5-HT3Br2 subunits was again somewhat intermediate
between those of 5-HT3A and 5-HT3AB receptors,
although parameters obtained from concentration–response curves
were not significantly different to those obtained from 5-HT3A receptors. These data could indicate that the 5-HT3Br2 subunit
is being incorporated into receptors, but has no effect on receptor
parameters. To test this, we examined the potency of picrotoxinin.
This compound acts in the pore and has differing potencies at 5-HT3A and 5-HT3AB receptors (IC50s of 11
and 62 μM respectively) due to the different pore lining residues
contributed by the 5-HT3B (and similarly the 5-HT3Br1 and 5-HT3Br2)
subunits.[15] Here picrotoxinin had an IC50 of 17 μM (pIC50 = 4.77 ± 0.14, n = 3), which is not significantly different from the value
obtained for 5-HT3A receptors (pIC50 = 4.97
± 0.12, n = 13), suggesting the 5-HT3Br2 subunit
was not part of the functional receptor.
Characterization of 5-HT3ABr2 Receptors in HEK Cells
Coexpression of 5-HT3A and 5-HT3Br2 receptor
subunits in HEK cells analyzed using membrane potential fluorescent
dye revealed concentration response parameters and shapes of traces
that were indistinguishable from those of 5-HT3A receptors
(Figure 3). Macroscopic currents measured in
the whole cell configuration from cells transfected with 5-HT3A and
5-HT3Br2 subunits (1:9 ratio) were similar to those of 5-HT3A receptors and clearly different to those of 5-HT3AB
receptors (Figure 8).
Figure 8
Macroscopic and single-channel
recordings from HEK293 cells cotransfected
with 5-HT3A or in combination with 5-HT3B, 5-HT3Br1, or 5-HT3Br2 subunits.
Representative traces of macroscopic (top of each panel) and single-channel
currents (bottom of each panel) from cells transfected with only 5-HT3A
or together with 5-HT3Br2 or 5-HT3B subunits are shown (subunit ratio
1:3 for A:B and A:Br1, and 1:9 for A:Br2, total DNA was 4 μg/dish).
Macroscopic currents were recorded in the whole cell configuration
at a holding potential of −50 mV and were elicited by a pulse
of 100 μM 5-HT (gray bar). Single-channel currents were recorded
from cell-attached patches at −100 mV in the presence of 10
μM 5-HT. Channel openings are shown as upward deflections.
Macroscopic and single-channel
recordings from HEK293 cells cotransfected
with 5-HT3A or in combination with 5-HT3B, 5-HT3Br1, or 5-HT3Br2 subunits.
Representative traces of macroscopic (top of each panel) and single-channel
currents (bottom of each panel) from cells transfected with only 5-HT3A
or together with 5-HT3Br2 or 5-HT3B subunits are shown (subunit ratio
1:3 for A:B and A:Br1, and 1:9 for A:Br2, total DNA was 4 μg/dish).
Macroscopic currents were recorded in the whole cell configuration
at a holding potential of −50 mV and were elicited by a pulse
of 100 μM 5-HT (gray bar). Single-channel currents were recorded
from cell-attached patches at −100 mV in the presence of 10
μM 5-HT. Channel openings are shown as upward deflections.Moreover, despite the detection
of whole-cell macroscopic currents
in 5-HT3ABr2 transfected cells, no single channel events
were detected in 30 different patches from green cells and two different
transfections (ratios 1:3 and 1:9 of 5-HT3A:5-HT3Br2 subunits) (Figure 8). These data are therefore consistent with functional
expression of solely homomeric 5-HT3A receptors, whose
conductance is too low to allow detection of single channel openings.[16] It has been shown that only after the introduction
of the triple QDA mutation at determinants of ion conductance of the
5-HT3A subunit, which mimics the amino acids found in the 5-HT3B subunit,
single-channel openings of 5-HT3A receptors can be detected
under the present recording conditions.[16−18] Incorporation of even
one 5-HT3Br2 subunit into receptors should permit the detection of
such events, as this subunit possesses the high-conductance triple
QDA motif that can be readily detected even when only a single subunit
is present.[19,20]This apparent lack of incorporation
of the 5-HT3Br2 subunit into
functional heteromeric receptors is likely to be due to its unusual
sequence: this subunit is missing the β1-β2 loop and loop
D, which are essential for gating.[21] The
considerable abundance of 5-HT3Br2 mRNA in the brain, however,
suggests it is important.[11] This subunit
may therefore have some other role, and warrants further investigation.
Conclusion
This study demonstrates that the 5-HT3Br1 transcriptional
variant
of the 5-HT3B subunit can contribute to the functional properties
of heteromeric receptors in a similar manner to the originally characterized
5-HT3B subunit, altering the EC50, nH, and single channel conductance of the 5-HT3A
receptor. Its expression levels, however, differ significantly from
those of the canonical 5-HT3B subunits in heterologous systems. Conversely
the 5-HT3Br2 subunit does not form functional channels with the 5-HT3A
subunit in either oocytes or HEK cells. Its physiological role is
yet to be determined.
Methods
Materials
All cell culture reagents were obtained from
Gibco (Invitrogen Ltd., Paisley, U.K.), except fetal calf serum which
was from Labtech International (Ringmer, U.K.). Human 5-HT3A (accession number: P46098) and 5-HT3B (O95264) receptor
subunit cDNA was kindly gifted by Prof J. A. Peters (University of
Dundee, U.K.). 5-HT3Br1 and 5-HT3Br2 subunit cDNAs were generated
by Quikchange mutagenesis.
Oocyte Maintenance
Xenopus
laevis oocyte-positive
females were purchased from NASCO (Fort Atkinson, WI) and maintained
according to standard methods. Harvested stage V–VI Xenopus oocytes were washed in four changes of Ca-free ND96
(96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5),
defolliculated in 1.5 mg mL–1 collagenase Type 1A
for approximately 2 h, washed again in four changes of ND96, and then
stored in ND96 containing 2.5 mM sodium pyruvate, 50 mM gentamycin,
and 0.7 mM theophylline.
HEK293 Cell Culture
Human embryonic
kidney (HEK) 293
cells were maintained on 90 mm tissue culture plates at 37 °C
and 7% CO2 in a humidified atmosphere. They were cultured
in DMEM:F12 with GlutaMAX I media (Dulbecco’s modified Eagle’s
Medium/Nutrient Mix F12 (1:1), Invitrogen, Paisley, U.K.) containing
10% fetal calf serum. Cells in 90 mm dishes were transfected using
polyethylenimine (PEI). Then 30 μL of PEI (1 mg/mL), 4 μL
of cDNA (1 mg/mL) and 1 mL of DMEM were incubated for 10 min at room
temperature, added dropwise to a 80–90% confluent plate, and
incubated for 2–3 days. For Flexstation studies, cells were
transferred to 96-well plates and allowed to adhere overnight before
use.
Receptor Expression
cDNA was cloned into pGEMHE for
oocyte expression, and pcDNA3.1 (Invitrogen, Paisley, U.K.) for expression
in HEK 293 cells. Mutagenesis (Figure 1) was
performed using QuikChange (Agilent Technologies Inc., Santa Clara,
CA). cRNA was in vitro transcribed from linearized pGEMHE cDNA template
using the mMessage mMachine T7 Transcription kit (Ambion, Austin,
TX). 5-HT3A was linearized with SphI and 5-HT3B cDNA with NheI. Stage
V and VI oocytes were injected with 50 nL of ∼400 ng μL–1 cRNA, and currents were recorded 1–4 days
postinjection. Ratios of 1:3 (5-HT3A:5-HT3B/5-HT3Br1/5-HT3Br2) were
used for the expression of heteromeric receptors unless otherwise
stated. These levels were previously found to be optimal for 5-HT3AB receptor expression, as ratios ≤1:1 resulted in
more 5-HT3A receptor-like responses and ≥1:10 showed
poorer total receptor expression.
Fluorometric Analysis
This was as previously described.[22] In
brief, fluorescent membrane potential dye
(Membrane Potential Blue kit, Molecular Devices) was diluted in Flex
buffer (10 mM HEPES, 115 mM NaCl, 1 mM KCl, 1 mM CaCl2,
1 mM MgCl2, and 10 mM glucose, pH 7.4) and 100 μL
added to each well of transfected cells. The cells were incubated
at 37 °C for 45 min, and then fluorescence was measured in a
FlexStation (Molecular Devices) at 2 s intervals for 200 s. 5-HT (Sigma)
was added to each well after 20 s. Analysis and curve fitting was
performed using Prism (GraphPad Software, San Diego, CA, www.graphpad.com).
TEVC Electrophysiology
Using two electrode voltage-clamp, Xenopus oocytes were clamped at −60 mV using an OC-725
amplifier (Warner Instruments, Hamden, CT), Digidata 1322A, and the
Strathclyde Electrophysiology Software Package (Department of Physiology
and Pharmacology, University of Strathclyde, UK). Currents were recorded
at a frequency of 5 kHz and filtered at 1 kHz. Microelectrodes were
fabricated from borosilicate glass (GC120TF-10, Harvard Apparatus,
Edenbridge, Kent, U.K.) using a one stage horizontal pull (P-87, Sutter
Instrument Company, Novato, CA) and filled with 3 M KCl. Pipet resistances
ranged from 1.0 to 2.0 MΩ. Oocytes were perfused with saline
at a constant rate of 12 mL min–1. Drug application
was via a simple gravity fed system calibrated to run at the same
rate. Extracellular saline contained (mM), 96 NaCl, 2 KCl, 1 MgCl2, and 5 mM HEPES; pH 7.4 with NaOH).Concentration–response
data for each oocyte was normalized to the maximum current for that
oocyte, and analysis and curve fitting was performed using Prism.
Whole-Cell Patch-Clamp Electrophysiology
Macroscopic
current recordings were recorded in the whole-cell configuration essentially
as described before.[17] For whole-cell recordings,
the perfusion system consisted of solution reservoirs, manual switching
valves, a solenoid-driven pinch valve, and two tubes (inner diameter,
0.3 mm) oriented at 90° inserted into the culture dish (modified
from ref (23)). One
tube contained extracellular solution (ECS) without agonist (normal
solution), and the other contained ECS with of 5-HT (test solution).
A series of 1.5 s pulses of ECS containing 100 μM 5-HT were
applied at 15 s intervals. The pipet solution contained 134 mM KCl,
5 mM EGTA, 1 mM MgCl2, and 10 mM HEPES, pH 7.3. The extracellular
solution contained 150 mM NaCl, 5.6 mM KCl, 0.5 mM CaCl2, and 10 mM HEPES, pH 7.3. Macroscopic currents were recorded at
an applied potential of −50 mV, filtered at 5 kHz, and digitized
at 20 kHz. Data analysis was performed using the IgorPro software
(Wavemetrics). For each experiment, three to five individual records
were aligned at the point at which the current reached 50% of maximum,
and expressed as their average. The solution exchange time was estimated
by placing an open pipet at the cell position, and switching from
normal bath solution to a diluted (1:1 with water) bath solution.
Typical times varied between 1 and 2 ms.
Single-Channel Patch-Clamp
Recordings
Single-channel
recordings were obtained in the cell-attached patch configuration
essentially as described before.[17] The
bath and pipet solutions contained 142 mM KCl, 5.4 mM NaCl, 0.2 mM
CaCl2, and 10 mM HEPES, pH 7.4. Single-channel currents
were recorded and low-pass filtered to 10 kHz using an Axopatch 200
B patch-clamp amplifier (Molecular Devices), digitized at 5 μs
intervals, and detected by the half a mplitude threshold criterion
using the program TAC (Bruxton Corporation). Open-time histograms
were fitted by the sum of exponential functions by maximum likelihood
using the program TACFit (Bruxton Corporation). Bursts were identified
as a series of closely separated openings (more than five) preceded
and followed by closings longer than a critical duration. The critical
time was taken as the point of intersection of the second and the
third component in the closed-time histogram for bursts (τcb). Typically, τcb were
between 0.2 and 0.6 ms. Burst duration was obtained from the longest
duration component of the open-time histogram constructed with the
critical time for defining bursts.
Radioligand Binding
Transfected HEK 293 cells were
scraped into 1 mL of ice-cold HEPES buffer (10 mM, pH 7.4) and frozen.
After thawing, they were washed with HEPES buffer and resuspended,
and then 50 μg of cell membranes was incubated in 0.5 mL of
HEPES buffer containing 1 nM [3H]granisetron (∼Kd) in a total volume of 500 μL. Nonspecific
binding was determined using 1 mM quipazine or 10 μM d-tubocurarine,
giving the same result. For competition binding (8 point), reactions
were incubated for at least 1 h at 4 °C. Reactions were terminated
by vacuum filtration using a Brandel cell harvester onto GF/B filters
presoaked in 0.3% polyethylenimine. Radioactivity was determined by
scintillation counting using a Beckman BCLS6500 instrument (Fullerton,
CA). Individual competition binding experiments were analyzed by iterative
curve fitting using Prism.
Statistical Analysis
Statistical
analysis was performed
using Prism using Student’s t test or one-way
ANOVA as appropriate, and p < 0.05 was taken as
statistically significant.
Authors: C A Brady; I M Stanford; I Ali; L Lin; J M Williams; A E Dubin; A G Hope; N M Barnes Journal: Neuropharmacology Date: 2001-08 Impact factor: 5.250